Home »
Academic Articles & Research Papers
Showing 20 of 61 academic articles
Kamalakar K, Akerele C, Lafont E, Koralnik LR et al. • Nutrients
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/nu18193146
PMC: PMC13666574
Parkinson EW • Proceedings of the National Academy of Sciences of the United States of America
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1073/pnas.2505519123
PMC: PMC13123814
Jacob AA, Rout S, Dash R, Venugopal G et al. • Neurodegenerative disease management
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1080/17582024.2025.2574204
PMC: PMC13192096
Aldakheel A, Qadi N • Nutrients
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/nu18203436
PMC: PMC13708064
Momahhed SS, Haghighathoseini A • PloS one
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1371/journal.pone.0360944
PMC: PMC13730354
Meng Zhang, Ping He, Zhigang Bian • Frontiers in Molecular Neuroscience
(2021)
Neurodegenerative diseases (NDDs), including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), and amyotrophic lateral sclerosis (ALS), are progressive and ultimately fatal. NDD onset is influenced by several fa...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnmol.2021.685143
Anna Pratima Nikalje • Medicinal Chemistry
(2015)
Nanotechnologyis the study of extremely small structures, having size of 0.1 to 100 nm. Nano medicine is a relatively new field of science and technology. Brief explanation of various types of pharmaceutical nano systems is given. Classific...
OPENALEX
DOI: https://doi.org/10.4172/2161-0444.1000247
Noela Rodriguez-Losada, Noela Rodriguez-Losada, Rune Wendelbob, M. Carmen Ocaña et al. • Frontiers in Neuroscience
(2020)
Emerging scaffold structures made of carbon nanomaterials, such as graphene oxide (GO) have shown efficient bioconjugation with common biomolecules. Previous studies described that GO promotes the differentiation of neural stem cells and ma...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fnins.2020.570409
Khushboo Singh, Roon Banerjee, Chandrakanta Potdar, Anisha Shaw et al. • Cells
(2026)
Mutations in leucine-rich repeat kinase 2 (LRRK2) are among the most common genetic causes of Parkinson’s disease (PD), yet substantial heterogeneity exists among pathogenic variants. How mutations in distinct functional domains of LRRK2 di...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/cells15040342
Sangmo Hong, Kyungdo Han, Cheol-Young Park • Endocrinology and Metabolism
(2025)
Acromegaly is a rare endocrine disorder caused by excessive growth hormone secretion. Its low prevalence poses challenges in studying its long-term prognosis and systemic effects. To address this research gap, we conducted five studies usin...
DOAJ
Open Access (DOAJ)
DOI: 10.3803/EnM.2024.2285
Tristan Curteis, Augustine Wigle, Christopher J. Michaels, Adriani Nikolakopoulou • BMC Medical Research Methodology
(2025)
Abstract Background In network meta-analysis (NMA), the magnitude of difference between treatment effects is typically ignored in the calculation of ranking metrics, such as probability best and surface under the cumulative ranking curve (S...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12874-025-02499-0
Fannie Darlot, Cécile Moro, Napoléon Torres‑Martinez, Claude Chabrol et al. • Revue de Primatologie
(2015)
La maladie de Parkinson (MP) est une maladie neurodégénérative chronique affectant le système dopaminergique et se traduisant par une perte des neurones dopaminergiques (DA) de la substance noire compacta (SNc) et des faisceaux nigro-striés...
DOAJ
Open Access (DOAJ)
DOI: 10.4000/primatologie.2073
Legoabe LJ, Petzer A, Petzer JP • Drug Design, Development and Therapy
(2015)
Lesetja J Legoabe,1 Anél Petzer,1 Jacobus P Petzer1,21Centre of Excellence for Pharmaceutical Sciences, 2Department of Pharmaceutical Chemistry, School of Pharmacy, North-West University, Potchefstroom, South AfricaAbstract: Based on...
DOAJ
Open Access (DOAJ)
Thomas F. Parkinson • Nuclear Science and Engineering
(1961)
"Elements of Nuclear Engineering." Nuclear Science and Engineering, 11(2), pp. 232–233 Additional informationNotes on contributorsT. F. Parkinson(Editor’s Note: Tom Parkinson was with Savannah River Laboratory for eight years immediately fo...
OPENALEX
DOI: https://doi.org/10.13182/nse61-a28074
Stewart F. Graham, Nolwen L. Rey, Zafer Ugur, Ali Yilmaz et al. • Metabolites
(2018)
For people with Parkinson’s disease (PD), considered the most common neurodegenerative disease behind Alzheimer’s disease, accurate diagnosis is dependent on many factors; however, misdiagnosis is extremely common in the prodrom...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/metabo8040071
Majed Alluqmani, Abdulfatah M. Alayoubi, Jamil A. Hashmi, Jamil A. Hashmi et al. • Frontiers in Genetics
(2024)
BackgroundVariants in a gene encoding sodium voltage-gated channel alpha subunit 1 (SCN1A) are known to cause a broad clinical spectrum of epilepsy and associated features, including Dravet syndrome (MIM 607208), non-Dravet developmental an...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fgene.2024.1496683
Priya Sharma, Talia Vasaturo-Kolodner, Valentina Mancini, Nicholas Shackle et al. • Brain Stimulation
(2025)
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.brs.2025.05.066
Lufei Chen, Chaoxian Dai, Zhenfang Wu, Yuhan Lin et al. • Journal of Xenobiotics
(2026)
Accumulating epidemiological evidence links ambient PM2.5 exposure to elevated Parkinson’s disease (PD) risk, yet the neurotoxicity triggered by PM2.5 multi-pollutant mixtures under real co-exposure scenarios remains insufficiently elucidat...
DOAJ
Open Access (DOAJ)
DOI: 10.3390/jox16060184
Joanna E. Klopotowska, Paul F. M. Kuks, Peter C. Wierenga, Clementine C. M. Stuijt et al. • BMC Geriatrics
(2022)
Abstract Background The effectiveness of interventions to improve medication safety in older inpatients is unclear, given a paucity of properly designed intervention studies applying clinically relevant endpoints such as hospital-acquired p...
DOAJ
Open Access (DOAJ)
DOI: 10.1186/s12877-022-03118-z
Emma A. Honkanen, Mikael Eklund, Simo Nuuttila, Tommi Noponen et al. • NeuroImage: Clinical
(2021)
Objective: To evaluate possible differences between brain dopamine transporter (DAT) binding in a group of symptomatic parkinsonism patients without dopaminergic degeneration and healthy individuals. Background: Dopaminergic neuroimaging st...
DOAJ
Open Access (DOAJ)
DOI: 10.1016/j.nicl.2021.102807